Studies show that most individuals regain a significant amount of weight after stopping GLP-1 drugs unless they pair treatment with sustained lifestyle changes. Patients using GLP-1 therapy as a temporary tool should focus on improving diet, building exercise habits, and preserving muscle mass to enhance long-term success
People taking GLP-1 medications commonly report reduced food cravings, less emotional eating, and a quieting of the constant mental preoccupation with food that researchers call "food noise." Animal studies have also shown that GLP-1 receptor activation reduces the rewarding properties of high-calorie food in the brain findings confirmed in a landmark randomized, placebo-controlled neuroimaging study in humans ( van Bloemendaal et al., Diabetes, 2014 )
and has served as a consultant fees from AbbVie, Amgen, Bristol Myers Squibb, Celgene, CorEvitas, Lilly, Gilead, Happify, Janssen, Novartis, Pfizer and UCB
That is approximately 71 pounds for the average participant
,aspect=ignore)
